IMV Inc. (IMV)
Company Description
IMV Inc. operates as a clinical-stage immuno-oncology company.
The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers.
The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer.
It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases.
The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018.
IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
| Country | CA |
| IPO Date | Oct 24, 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 63 |
| CEO | Andrew Hall |
Contact Details
Address: 130 Eileen Stubbs Avenue Dartmouth, NS CA | |
| Website | https://www.imv-inc.com |
Stock Details
| Ticker Symbol | IMV |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001734768 |
| CUSIP Number | 44974L103 |
| ISIN Number | CA44974L1031 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Andrew Hall M.Sc. | Chief Executive Officer & Director |
| Jennifer Schmitke Ph.D. | Acting Chief Operating Officer |
| Brittany Davison C.A., C.P.A. | Chief Accounting Officer, Corporation Sec. & Director |
| Brittany Davison C.A., CPA | Chief Accounting Officer, Corporation Sec. & Director |
| Delphine Davan | Senior Director of Communications & Investor Relations |
| Dr. Heather Hirsch | Vice President of Translational Research |
| Dr. Heather Hirsch Ph.D. | Vice President of Translational Research |
| Dr. Jeremy R. Graff | Chief Scientific Officer |
| Dr. Jeremy R. Graff Ph.D. | Chief Scientific Officer |
| Dr. Marianne Stanford | Vice President of R&D |
| Linda Barabe M.B.A. | Senior Vice President of HR |
| Stephan Fiset | Vice President of Clinical Research |
| Stephan Fiset M.B.A., M.Sc. | Vice President of Clinical Research |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 22, 2023 | 15-12G | Filing |
| Sep 22, 2023 | F-10POS | Filing |
| Sep 22, 2023 | F-10POS | Filing |
| Sep 22, 2023 | F-10POS | Filing |
| Sep 22, 2023 | S-8 POS | Filing |
| Sep 22, 2023 | S-8 POS | Filing |
| Sep 22, 2023 | S-8 POS | Filing |
| Sep 22, 2023 | S-8 POS | Filing |
| Sep 22, 2023 | S-8 POS | Filing |
| Jul 26, 2023 | 6-K | Filing |